Concepedia

Michael R. Leadbetter

MR

Statistics

Publications

13

Citations

986

H-Index

13

Active since

1968

Affiliations

Ardelyx (United States)(Current)

Yale University

Theravance Biopharma (United States)

Michael R. Leadbetter is an author at Ardelyx (United States) specializing in medicine, pharmacology, and gastroenterology.

Top concepts

Publications per year

1968–2022

13

Publications

13

Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform

Kenji Kozuka, Ying He, Samantha Koo-McCoy et al. · Stem Cell Reports · 2017 · 168 citations · Full text

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 163 citations · Full text

Intestinal Inhibition of the Na <sup>+</sup> /H <sup>+</sup> Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na <sup>+</sup> Uptake in Humans

Andrew Spencer, Eric D. Labonté, David P. Rosenbaum et al. · Science Translational Medicine · 2014 · 146 citations

Nonradioactive nucleic acid detection by enhanced chemiluminescence using probes directly labeled with horseradish peroxidase

Denise Pollard-Knight, Christopher A. Read, M. J. Downes et al. · Analytical Biochemistry · 1990 · 111 citations

, , +9

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD

Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter et al. · Journal of the American Society of Nephrology · 2014 · 104 citations · Full text

, , +21

1–5 of 13